Quantitative G6PD Deficiency Screening in Routine Malaria Diagnostic Units in the Brazilian Amazon (SAFEPRIM): An Operational Mixed-Methods Study

Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency testing is not routinely performed before primaquine treatment in most <i>Plasmodium vivax</i> endemic areas, despite the risk of primaquine-associated hemolysis. This is due to the operational challenges associated with pragmatic G6PD...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Jose Diego Brito-Sousa, Felipe Murta, Sheila Vitor-Silva, Vanderson Sampaio, Maxwell Mendes, Brenda Souza, Talita Batista, Alicia Santos, Leonardo Marques, Laila Barbosa, Patricia Balieiro, Alexandre Silva-Neto, Renata Rabello, Marcelo Brito, Emanuelle Silva, Sheila Rodovalho, Ana Ruth Arcanjo, Gisely Melo, Judith Recht, Gonzalo J. Domingo, Suiane Valle, Rodrigo Souza, Theresa Nakagawa, Wuelton Monteiro, Marcus Lacerda
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2022-11-01
סדרה:	Pathogens
נושאים:	G6PD deficiency <i>Plasmodium vivax</i> implementation malaria elimination primaquine
גישה מקוונת:	https://www.mdpi.com/2076-0817/11/11/1328
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!